Hematology & Onco-Hematology

Hematology & Onco-Hematology at UMC Hospitals, Nashik

Persistent tiredness, repeated infections, unexplained bruising, abnormal bleeding, or unusual blood test results can sometimes indicate an underlying blood disorder. The Department of Hematology & Onco-Hematology at UMC Hospitals, the best hematology hospital in Nashik, provides comprehensive care for conditions affecting the blood, bone marrow, lymphatic system, and blood-forming tissues.

Our services cover both benign and malignant haematological conditions, ranging from common forms of anaemia and bleeding disorders to complex blood cancers such as leukaemia, lymphoma, multiple myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms.

Our haematology specialists follow a personalized, multidisciplinary approach to diagnosis and treatment. Depending on the patient's condition, care may include outpatient consultations, advanced laboratory investigations, transfusion support, day-care therapies, inpatient management, chemotherapy, targeted treatments, supportive care, and coordination for stem cell transplantation when indicated.

The department works closely with haematopathology, oncology, transfusion medicine, critical care, laboratory services, and other relevant specialties to provide coordinated care throughout the patient's treatment journey.

Conditions We Treat

Anaemia and Red Blood Cell Disorders

We evaluate and manage different types of anaemia, including iron deficiency anaemia, vitamin B12 or folate deficiency, haemolytic anaemia, and anaemia associated with chronic diseases. Treatment is directed toward correcting deficiencies, identifying the underlying cause, and providing blood transfusion support when medically required.

Bleeding and Clotting Disorders

Our team provides evaluation and treatment for conditions that affect normal blood clotting, including haemophilia, von Willebrand disease, thrombophilia, deep vein thrombosis (DVT), pulmonary embolism, and disseminated intravascular coagulation (DIC). Treatment may involve factor replacement, anticoagulant therapy, and regular monitoring.

Haemoglobin Disorders

Inherited disorders such as thalassemia and sickle cell disease require long-term monitoring and coordinated care. Management may include transfusion support, iron overload assessment, chelation therapy, vaccination, infection prevention, and monitoring for disease-related complications.

Platelet and Immune Disorders

Low or abnormal platelet counts can result from several underlying conditions. We provide evaluation and management of disorders such as immune thrombocytopenia (ITP), thrombotic thrombocytopenic purpura (TTP), and selected immune-mediated and bone marrow disorders.

Bone Marrow Disorders

Abnormal blood counts may sometimes result from diseases affecting the bone marrow. Our specialists evaluate conditions such as aplastic anaemia, myelodysplastic syndromes, and other disorders affecting blood-cell production.

Haematological Cancers

The Onco-Hematology service focuses on cancers involving the blood, bone marrow, lymph nodes, and related tissues. These include:

• Acute and chronic leukaemias
• Hodgkin and non-Hodgkin lymphomas
• Multiple myeloma
• Myelodysplastic syndromes (MDS)
• Myeloproliferative neoplasms (MPNs)
• Other malignant disorders of the blood and bone marrow

Treatment is planned according to the specific disease, stage, molecular characteristics, response to therapy, and overall health of the patient.

Diagnostic Services

Accurate diagnosis is essential for selecting the right haematology or onco-hematology treatment. At UMC Hospitals, Nashik, investigations are recommended based on symptoms, clinical examination, previous reports, and suspected diagnosis.

• Complete Blood Count and Peripheral Smear
  A complete blood count provides important information about red blood cells, white blood cells, haemoglobin, and platelets. Examination of a peripheral blood smear can provide additional information about the size, shape, and appearance of blood cells and may help identify abnormalities requiring further evaluation.
• Coagulation Profile
  Tests such as PT/INR, aPTT, fibrinogen, and D-dimer may be used to investigate abnormal bleeding, clotting disorders, or suspected thrombotic conditions.
• Bone Marrow Aspiration and Biopsy
  Bone marrow examination may be recommended when unexplained abnormalities in blood counts are present or when a bone marrow disorder or blood cancer is suspected. The procedure is generally performed under local anesthesia and can provide important information for diagnosis, classification, and treatment planning.
• Flow Cytometry
  Flow cytometry helps identify and characterize abnormal blood or bone marrow cells. It is an important diagnostic tool for several types of leukaemia, lymphoma, and other haematological disorders.
• Cytogenetic and Molecular Investigations
  Chromosomal and molecular studies, including cytogenetics, FISH, and selected molecular assays, can help identify genetic changes associated with particular blood disorders and cancers. These results may assist in diagnosis, risk assessment, prognosis, and treatment selection.
• Hemoglobinopathy Testing
  Specialized testing such as HPLC-based haemoglobin analysis can help diagnose and classify inherited haemoglobin disorders, including thalassemia and sickle cell disease.
• Additional Hematology Investigations
  Depending on the patient's condition, additional tests may include iron studies, vitamin levels, haemolysis-related investigations, protein electrophoresis, immunological testing, and other specialized laboratory investigations.

Hematology and Onco-Hematology Treatments

• Blood Transfusion Services
  Patients requiring blood component support may receive packed red blood cells, platelets, plasma, or cryoprecipitate based on their clinical requirements, with appropriate compatibility testing and monitoring.
• Chemotherapy
  Chemotherapy is used for several haematological malignancies, with treatment schedules selected according to the type and stage of cancer, disease biology, treatment response, and patient tolerance.
• Targeted Therapy
  Targeted medicines may be used for certain blood cancers with specific molecular or cellular changes, based on the patient's diagnosis and relevant laboratory or molecular findings.
• Immunotherapy
  Immunotherapy may be recommended for selected blood cancers to help the immune system recognize and attack abnormal cells, depending on the specific disease characteristics.
• Supportive Hematology Care
  Supportive management may include care for anaemia, low platelet counts, infections, nutritional deficiencies, treatment-related symptoms, and other complications.
• Iron Chelation Therapy
  Patients receiving repeated blood transfusions may undergo monitoring for iron overload and receive iron chelation therapy when appropriate to reduce the risk of long-term complications.
• Anticoagulation Management
  Hematology services may include anticoagulant dose management, assessment of bleeding and clotting risks, and planning around surgeries or other invasive procedures.
• Haemophilia and Bleeding Disorder Management
  Management may include clotting factor replacement, inhibitor management, preventive strategies, and education for recognizing and managing bleeding episodes.
• Thalassemia and Sickle Cell Care
  Long-term care may include clinical monitoring, transfusion support, iron overload assessment, chelation therapy, vaccination guidance, infection prevention, nutritional support, and monitoring for complications.
• Stem Cell Transplant Evaluation and Coordination
  Selected patients with blood cancers or bone marrow disorders may undergo specialist evaluation, pre-transplant assessment, transplant centre coordination, and post-transplant follow-up planning.

Why Choose UMC Hospitals for Hematology & Onco-Hematology in Nashik?

UMC Hospitals, Nashik, provides comprehensive care for blood disorders and haematological cancers through specialist-led diagnosis, advanced investigations, personalized treatment, and multidisciplinary support.

Our key strengths include:

• Comprehensive management of benign and malignant blood disorders
• Dedicated Hematology and Onco-Hematology services
• Advanced diagnostic support including blood investigations, peripheral smear, bone marrow examination, flow cytometry, cytogenetics, FISH, and molecular testing
• Day-care treatment options for selected chemotherapy, transfusion, and supportive therapies
• Safe and monitored blood component transfusion services
• Individualized treatment plans for leukaemia, lymphoma, multiple myeloma, MDS, MPNs, and other haematological malignancies
• Long-term management programs for thalassemia, sickle cell disease, haemophilia, and other chronic blood disorders
• Specialized support for bleeding and clotting disorders
• Anticoagulation management and monitoring
• Evaluation and coordination for stem cell transplantation when indicated
• Multidisciplinary collaboration with oncology, haematopathology, transfusion medicine, critical care, laboratory medicine, and other specialties
• Focus on infection prevention, treatment safety, symptom management, and structured follow-up

Book an Appointment for Hematology & Onco-Hematology Care in Nashik

If you are experiencing persistent fatigue, unexplained bruising or bleeding, recurrent infections, abnormal blood counts, or have been diagnosed with a blood disorder or haematological cancer, the Hematology & Onco-Hematology team at UMC Hospitals, Nashik, can provide comprehensive evaluation and personalized treatment.

Whether you require diagnosis, ongoing disease management, cancer treatment, transfusion support, or a second opinion, consult our experienced hematologists in Nashik for guidance on appropriate investigations, treatment options, and follow-up care.

Frequently Asked Questions

• What does a haematologist treat?
  A haematologist specializes in disorders affecting the blood, bone marrow, and related systems. These include anaemia, platelet disorders, bleeding and clotting conditions, thalassemia, sickle cell disease, bone marrow disorders, and blood cancers such as leukaemia, lymphoma, and multiple myeloma.
• When should I consult a haematologist?
  A haematology consultation may be appropriate when blood tests show unexplained or persistent abnormalities, such as low haemoglobin, abnormal white blood cell counts, unusual platelet levels, recurrent infections, unexplained bruising or bleeding, or repeated blood clots.
• Does an abnormal blood count always mean cancer?
  No. Abnormal blood counts can result from many conditions, including nutritional deficiencies, infections, medications, chronic diseases, immune disorders, and other medical problems. A haematologist can evaluate the findings and determine whether further testing is necessary.
• Why is a bone marrow biopsy performed?
  A bone marrow biopsy may be recommended when blood counts are persistently abnormal without an obvious explanation or when a bone marrow disorder or blood cancer is suspected. It can provide important information about blood-cell production and help establish or classify a diagnosis.
• What treatments are available for blood cancers?
  Treatment depends on the specific type and characteristics of the blood cancer. Options may include chemotherapy, targeted therapy, immunotherapy, radiation therapy, supportive treatment, or stem cell transplantation in selected patients.